Press Releases ReproCELL Incorporated

Equities

4978

JP3974770004

Delayed Japan Exchange Other stock markets 11:50:57 2024-05-19 pm EDT			5-day change	1st Jan Change
134 ^JPY	+1.52%		+1.52%	-23.43%

2023	ReproCELL Incorporated announced that it has received ¥5.3 million in funding from Morgan Stanley MUFG Securities Co., Ltd.	CI
2023	ReproCELL Incorporated announced that it expects to receive ¥5.3 million in funding	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Clinical Trials: An Evolutionary Perspective	23-01-18	PU
ReproCELL Incorporated : 4 ways ex vivo models offer Pharma better alternatives to animal testing	22-10-31	PU
ReproCELL Incorporated : How human fresh tissue models are helping RCD405 achieve regulatory approval	22-08-17	PU
ReproCELL Incorporated : Everything we know about the 5HT1B receptor	22-04-21	PU
ReproCELL Incorporated : Skin biopsy and ex vivo culture methods	22-03-29	PU
ReproCELL Incorporated : The influence of the microbiome on inflammatory bowel diease	22-03-18	PU
ReproCELL Incorporated : What is Human Tissue Testing?	22-03-14	PU
ReproCELL Incorporated : co-author paper with IBM showcasing a novel ML driven precision medicine strategy for drug development	22-03-08	PU
ReproCELL Incorporated : Solutions for Skin Disease Researchers	22-03-04	PU
ReproCELL Incorporated : Predicting Psoriasis Drug Efficacy in Human Skin	22-03-03	PU
ReproCELL Incorporated : How SynFire® Technology can benefit your research	22-03-03	PU
ReproCELL Incorporated : Inserts or plates for your 3D cell culture?	22-02-28	PU
ReproCELL Incorporated : How to improve your 3D Cell Culture using Small-scale Perfusion Systems	22-02-15	PU
ReproCELL Incorporated : Biotechgate Digital Partnering 2022 7 - 11 February 2022 • Virtual Meeting	22-02-09	PU
ReproCELL Incorporated : Enhance your epithelial barriers assay using Alvetex	22-02-07	PU
ReproCELL Incorporated : spotlights the power of smarter biospecimens in new global publication	22-01-20	PU
ReproCELL Incorporated : Everything you need to know about the REPROCELL iPSC Biobank	21-11-30	PU
ReproCELL Incorporated : How we established an in vitro Parkinson’s Disease model	21-11-24	PU
ReproCELL Incorporated : What is Human Tissue Testing?	21-10-14	PU
ReproCELL Incorporated : How digital PCR can improve CRISPR gene editing (with examples)	21-10-05	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases ReproCELL Incorporated

Equities

4978

JP3974770004

Press Releases

Filters